why choose us

First received: September 06, 2023

Clinical Trial: DZD9008 PK Study in Hepatic Impairment Subjects

Study Status: Completed

Recruit Status: RECRUITING

Condition: Hepatic Impairment

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Single-Dose, Non-Randomized, Open Label Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of DZD9008

Brief Summary: This study will investigate the pharmacokinetics, safety, and tolerability of DZD9008 in subjects with hepatic impairment compared to subjects with normal hepatic function

Read more